These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35847888)

  • 21. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the Expression Profile of Autophagy-Related Genes in Colon Adenocarcinoma.
    Hou M; Ma J; Ma J
    Comput Math Methods Med; 2022; 2022():7525048. PubMed ID: 35572821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a prognostic risk model of colorectal adenocarcinoma through integrated analysis of RNA-binding proteins.
    Liu X; Lv Q; Jing Z; Long X; Yi R; Yang D; Zhao X
    Transl Cancer Res; 2021 May; 10(5):1962-1974. PubMed ID: 35116519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Luo B; Lin J; Cai W; Wang M
    Front Genet; 2021; 12():771847. PubMed ID: 34938319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma.
    Yang W; Luo C; Chen S
    Front Genet; 2022; 13():986325. PubMed ID: 36506326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
    Luo HY; Tang WL; Xiang L; Peng LL; Wu DB; Zhu ZY; Gu HT; Tang YH; Perkins RS; Shen HY; Wang YX
    J Gastrointest Oncol; 2022 Dec; 13(6):3025-3037. PubMed ID: 36636093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
    Jin LP; Liu T; Meng FQ; Tai JD
    BMC Cancer; 2020 Oct; 20(1):968. PubMed ID: 33028275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma.
    Chen P; Yu J; Luo Q; Li J; Wang W
    BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
    Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
    PeerJ; 2018; 6():e4942. PubMed ID: 29915691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Ten-N
    Huang W; Li G; Wang Z; Zhou L; Yin X; Yang T; Wang P; Teng X; Feng Y; Yu H
    Front Oncol; 2020; 10():567931. PubMed ID: 33680913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
    Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
    Front Genet; 2021; 12():635863. PubMed ID: 33719345
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.
    Fu X; Duanmu J; Li T; Jiang Q
    PeerJ; 2020; 8():e8877. PubMed ID: 32309045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.